IL-1β and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes

References

• Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996; 5: 191–202
   PubMedGoogle Scholar
• Atherton JC, Peek RM, Jr, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92–9
   PubMed Web of Science ®Google Scholar
• Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648–53
   PubMed Web of Science ®Google Scholar
• Prinz C, Schoniger M, Rad R, Becker I, Keiditsch E, Wagenpfeil S, et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001; 61: 1903–9
   PubMed Web of Science ®Google Scholar
• Li SD, Kersulyte D, Lindley IJ, Neelam B, Berg DE, Crabtree JE. Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun 1999; 67: 3893–9
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000; 97: 7533–8
   PubMed Web of Science ®Google Scholar
• Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H, et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 1992; 263: G719–25
   PubMed Web of Science ®Google Scholar
• Murakami M, Asagoe K, Dekigai H, Kusaka S, Saita H, Kita T. Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage. Dig Dis Sci 1995; 40: 268–73
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Lindley IJ. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur J Gastroenterol Hepatol 1994; 6 Suppl 1: S33–8
   PubMed Web of Science ®Google Scholar
• Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425–9
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997; 41: 442–51
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer (erratum appears in Nature ;412:99). Nature ;404 2001; 2000: 398–402
   Google Scholar
• Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823–9
   PubMed Web of Science ®Google Scholar
• Hwang IL, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1( production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793–803
   PubMed Web of Science ®Google Scholar
• Hamajima N, Matsuo K, Saito T, Tajima K, Okuma K, Yamao K, et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92: 383–9
   PubMedGoogle Scholar
• Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003; 104: 617–23
   PubMed Web of Science ®Google Scholar
• McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000; 289: 1202–6
   PubMed Web of Science ®Google Scholar
• Gooz M, Gooz P, Smolka AJ. Epithelial and bacterial metalloproteinases and their inhibitors in H. @ pylori infection of human gastric cells. Am J Physiol Gastrointest Liver Physiol 2001; 281: G823–32
   PubMed Web of Science ®Google Scholar
• Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor (B. Gastroenterology 2003; 124: 983–92
   PubMed Web of Science ®Google Scholar
• Bergin PJ, Anders E, Sicheng W, Erik J, Jennie A, Hans L, et al. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter 2004; 9: 201–10
   PubMed Web of Science ®Google Scholar
• Saarialho-Kere UK, Vaalamo M, Poulakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996; 148: 519–26
   PubMed Web of Science ®Google Scholar
• Gooz M, Shaker M, Gooz P, Smolka AJ. Interleukin 1( induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. Gut 2003; 52: 1250–6
   PubMed Web of Science ®Google Scholar
• Russo F, Messa C, Amati L, Caradonna L, Leoci C, Di Matteo G, et al. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor. Scand J Gastroenterol 1998; 33: 271–5
   PubMed Web of Science ®Google Scholar
• Messa C, Di Leo A, Greco B, Caradonna L, Amati L, Linsalata M, et al. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol Immunotoxicol 1996; 18: 1–13
   PubMed Web of Science ®Google Scholar
• Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 2004; 19: 1181–8
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161–81
   PubMed Web of Science ®Google Scholar
• Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1( genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36: 696–9
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095–147
   PubMed Web of Science ®Google Scholar
• Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1( cytokine in Korean patients with gastric cancer. Int J Cancer 2005; 114: 465–71
   PubMed Web of Science ®Google Scholar
• Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1( polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92–105
   PubMed Web of Science ®Google Scholar
• Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53: 1082–9
   PubMed Web of Science ®Google Scholar
• Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand J Gastroenterol 2005; 40: 530–9
   PubMed Web of Science ®Google Scholar
• Xuan J, Deguchi R, Watanabe S, Ozawa H, Urano T, Ogawa Y, et al. Relationship between IL-1( gene polymorphism and gastric mucosal IL-1( levels in patients with Helicobacter pylori infection. J Gastroenterol 2005; 40: 796–801
   PubMed Web of Science ®Google Scholar
• Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al. Genetic difference in interleukin-1( polymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res 2003; 22: 47–55
   PubMed Web of Science ®Google Scholar
• Miller RD, Phillips MS, Jo I, Donaldson MA, Studebaker JF, Addleman N, et al. The SNP Consortium Allele Frequency Project. High-density single-nucleotide polymorphism maps of the human genome. Genomics 2005; 86: 117–26
   PubMed Web of Science ®Google Scholar